Table 1

Univariate associations with urethral Mycoplasma genitalium in men with urethral gonorrhoea

M. genitalium detected
n (%)
M. genitalium not detected
n (%)
OR (95% CI)P value
Age (years)2.3 (0.5 to 10.7)0.2783
 <252/49 (4.1)47/49 (95.9)
 ≥2512/135 (8.9)123/135 (91.1)
Sex of partner/s0.7 (0.2 to 2.0)0.4654
 Male7/109 (6.4)102/109 (93.6)
 Female7/75 (9.3)68/75 (90.7)
Sexual partners last 3 months (n)
 Male*1.7 (0.4 to 6.7)0.4425
  0–10/14 (0.0)14/14 (100.0)
  2–53/54 (5.6)51/54 (94.4)
  ≥62/32 (6.3)30/32 (93.8)
 Female†1.5 (0.4 to 5.5)0.534
  0–11/19 (5.7)18/19 (94.7)
  2–55/46 (10.9)41/46 (89.1)
  ≥61/9 (11.1)8/9 (88.9)
Condom use last 3 months
 Never9/82 (11.0)73/82 (89.0)1.7 (0.8 to 3.8)0.1799
 Sometimes/usually4/75 (5.3)71/75 (94.5)
 Always/no vaginal or anal sex1/22 (4.6)21/22 (95.5)
PrEP‡, MSM only3.6 (0.6 to 23.3)0.1523
 Yes3/31 (9.7)28/31 (90.3)
 No2/69 (2.9)67/69 (97.1)
Urethral CT0.4 (0.1 to 3.1)0.3585
 Yes1/29 (3.5)28/29 (96.6)
 No13/155 (8.4)142/155 (91.6)
HIV seropositive0.5087
 Yes0/5 (0.0)5/5 (100.0)
 No14/173 (8.1)159/173 (91.9)
NG anorectal0.8 (0.1 to 4.8)0.8239
 Yes2/38 (5.3)4/65 (6.2)
 No36/38 (94.7)61/65 (93.9)
NG oropharyngeal0.4 (0.1 to 3.8)0.4173
 Yes1/32 (3.1)6/75 (8.0)
 No31/32 (96.9)69/75 (92.0)
CT anorectal1.9 (0.2 to 18.5)0.5692
 Yes1/10 (10.0)5/93 (5.4)
 No9/10 (90.0)88/93 (94.6)
CT oropharyngeal3.60 (0.3 to 37.0)0.2541
 Yes1/6 (16.7)6/102 (5.9)
 No5/6 (83.3)96/102 (94.1)
  • *Among MSM.

  • †Among heterosexual men.

  • ‡PrEP, on HIV pre-exposure prophylaxis.

  • CT, Chlamydia trachomatis; MSM, men who have sex with men; NG, Neisseria gonorrhoeae.